Skip to content

Clinical trials

Expanded access Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Expanded access Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Available5
No longer available5
Approved for marketing4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
AVM Biotechnology Inc1
Agenus Inc.1
Aveni Foundation1
CONKO-Studiengruppe1
Endevica Bio1
Fuda Cancer Hospital, Guangzhou1
Hope Biosciences LLC1
Impatients N.V. trading as myTomorrows1
Merus B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms14
Carcinoma, Non-Small-Cell Lung7
Breast Neoplasms5
Ovarian Neoplasms5
Prostatic Neoplasms5
Colorectal Neoplasms4
Head and Neck Neoplasms3
Melanoma3
Sarcoma3
Carcinoma, Hepatocellular2

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.